$ARKG monthly chart showing Ichimoku cloud penetration—wondering if we're about to see this pattern play out across other names too. This kind of technical breakout on the monthly timeframe usually signals a bigger shift in sentiment. If biotech/genomics is finally breaking structure after years of consolidation, could be early signal that risk appetite is rotating back into beaten-down innovation plays. Watch for confirmation in volume and whether other ARK names follow through. If this holds, it's not just one chart—it's a positioning shift.